DiaMedica Therapeutics Inc (DMAC)
3.00
+0.37
(+14.07%)
USD |
NASDAQ |
May 03, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Accounts Receivable (Quarterly): 0.071M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.071M |
September 30, 2023 | 0.001M |
June 30, 2023 | 0.002M |
March 31, 2023 | 0.002M |
December 31, 2022 | 0.002M |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | 0.002M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.016M |
March 31, 2021 | 0.044M |
December 31, 2020 | 0.017M |
September 30, 2020 | 0.008M |
June 30, 2020 | 0.018M |
March 31, 2020 | 0.039M |
December 31, 2019 | 0.017M |
September 30, 2019 | 0.025M |
June 30, 2019 | 0.031M |
March 31, 2019 | 0.047M |
December 31, 2018 | 0.024M |
September 30, 2018 | 0.4524M |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.08M |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.0004M |
December 31, 2015 | 0.0004M |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.0037M |
December 31, 2014 | 0.0084M |
September 30, 2014 | 0.0007M |
June 30, 2014 | 0.0007M |
March 31, 2014 | 0.0007M |
December 31, 2013 | 0.0007M |
September 30, 2013 | 0.0024M |
June 30, 2013 | 0.0017M |
March 31, 2013 | 0.0057M |
December 31, 2012 | 0.0028M |
September 30, 2012 | 0.0046M |
June 30, 2012 | 0.0026M |
March 31, 2012 | 0.0739M |
December 31, 2011 | 0.0066M |
September 30, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
0.071M
Maximum
Dec 2023
0.0174M
Average
0.016M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
NextCure Inc | -- |
NovaBay Pharmaceuticals Inc | 0.759M |
Palatin Technologies Inc | 2.346M |
iBio Inc | -- |
Theriva Biologics Inc | -- |